Mammalian Target of Rapamycin Regulates Vascular Endothelial Growth Factor–Dependent Liver Cyst Growth in Polycystin-2–Defective Mice
Carlo Spirlı̀(Cancer Research Center), Mario Strazzabosco(Smilow Cancer Hospital), Silvia Lecchi(Ospedale Papa Giovanni XXIII), Romina Fiorotto(Yale University), Massimiliano Cadamuro(University of Padua), S. Okolicsanyi(Azienda Ospedaliero Universitaria Ospedali Riuniti), Luca Fabris(University of Padua), Xin Tian(Yale University), Stefan Somlo(Yale University)
Cited by 95
Related Papers
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
|Hepatology|2018|340
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
|Hepatology|2020|302
Mutations in SEC63 cause autosomal dominant polycystic liver disease
|Nature Genetics|2004|282
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|187